NO962812D0 - Procedure for the treatment of pneumonia - Google Patents
Procedure for the treatment of pneumoniaInfo
- Publication number
- NO962812D0 NO962812D0 NO962812A NO962812A NO962812D0 NO 962812 D0 NO962812 D0 NO 962812D0 NO 962812 A NO962812 A NO 962812A NO 962812 A NO962812 A NO 962812A NO 962812 D0 NO962812 D0 NO 962812D0
- Authority
- NO
- Norway
- Prior art keywords
- pneumonia
- procedure
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK2094 | 1994-01-04 | ||
| PCT/DK1995/000003 WO1995018615A1 (en) | 1994-01-04 | 1995-01-03 | A method of treating neurogenic inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO962812D0 true NO962812D0 (en) | 1996-07-03 |
| NO962812L NO962812L (en) | 1996-09-04 |
Family
ID=8088844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO962812A NO962812L (en) | 1994-01-04 | 1996-07-03 | Procedure for the treatment of neurogenic inflammation |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0735872A1 (en) |
| JP (1) | JPH09507849A (en) |
| CN (1) | CN1142183A (en) |
| AU (1) | AU1311195A (en) |
| BR (1) | BR9506453A (en) |
| CA (1) | CA2180239A1 (en) |
| CZ (1) | CZ198396A3 (en) |
| FI (1) | FI962750A (en) |
| HU (1) | HUT76281A (en) |
| IL (1) | IL112223A0 (en) |
| NO (1) | NO962812L (en) |
| WO (1) | WO1995018615A1 (en) |
| ZA (1) | ZA9530B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997022342A1 (en) * | 1995-12-15 | 1997-06-26 | Novo Nordisk A/S | Novel method |
| US7417040B2 (en) | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2965639A (en) * | 1960-12-20 | New basically substituted azepine | ||
| FI864246A (en) * | 1985-11-08 | 1987-05-09 | Warner Lambert Co | N-SUBSTITUERADE 3-PIPERIDIN- ELLER 3-PYRIDINKARBOXYLSYROR SAMT DERAS DERIVAT. |
| DK93791D0 (en) * | 1991-05-17 | 1991-05-17 | Novo Nordisk As | NEW HETEROCYCLIC CARBOXYLIC ACIDS |
-
1995
- 1995-01-02 IL IL11222395A patent/IL112223A0/en unknown
- 1995-01-03 CN CN95191801A patent/CN1142183A/en active Pending
- 1995-01-03 CZ CZ961983A patent/CZ198396A3/en unknown
- 1995-01-03 JP JP7518276A patent/JPH09507849A/en active Pending
- 1995-01-03 AU AU13111/95A patent/AU1311195A/en not_active Abandoned
- 1995-01-03 HU HU9601826A patent/HUT76281A/en unknown
- 1995-01-03 EP EP95904410A patent/EP0735872A1/en not_active Withdrawn
- 1995-01-03 BR BR9506453A patent/BR9506453A/en not_active Application Discontinuation
- 1995-01-03 CA CA002180239A patent/CA2180239A1/en not_active Abandoned
- 1995-01-03 WO PCT/DK1995/000003 patent/WO1995018615A1/en not_active Application Discontinuation
- 1995-01-04 ZA ZA9530A patent/ZA9530B/en unknown
-
1996
- 1996-07-03 NO NO962812A patent/NO962812L/en unknown
- 1996-07-04 FI FI962750A patent/FI962750A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL112223A0 (en) | 1995-03-30 |
| FI962750A (en) | 1996-09-04 |
| JPH09507849A (en) | 1997-08-12 |
| ZA9530B (en) | 1996-07-04 |
| CZ198396A3 (en) | 1997-01-15 |
| CA2180239A1 (en) | 1995-07-13 |
| AU1311195A (en) | 1995-08-01 |
| EP0735872A1 (en) | 1996-10-09 |
| CN1142183A (en) | 1997-02-05 |
| BR9506453A (en) | 1997-09-02 |
| NO962812L (en) | 1996-09-04 |
| HUT76281A (en) | 1997-07-28 |
| HU9601826D0 (en) | 1996-09-30 |
| WO1995018615A1 (en) | 1995-07-13 |
| FI962750A0 (en) | 1996-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991955D0 (en) | Process for the treatment of hydrocarbons | |
| NO934304L (en) | Procedure for the treatment of fluoroalumosilicate glass | |
| NO976063D0 (en) | Procedure for the treatment of diabetes | |
| NO983284D0 (en) | Anticoagulants suitable for the treatment of thrombosis | |
| NO986052D0 (en) | Anticonvulsant derivatives for the treatment of obesity | |
| NO921777D0 (en) | PROCEDURE FOR THE MANUFACTURE OF ISOPARAFFINES | |
| NO972909D0 (en) | Substituted azetidin-2-ones for the treatment of atherosclerosis | |
| NO963785D0 (en) | Process for the treatment of 5HT2B receptor-related conditions | |
| NO991459L (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin infections | |
| NO972402D0 (en) | Process for the preparation of carriers | |
| NO20010456D0 (en) | Triazolopyridines for the treatment of thrombosis problems | |
| NO991734D0 (en) | Pyrazolinones for the treatment of potency disorders | |
| NO973366D0 (en) | Procedure for the treatment of multiple sclerosis | |
| NO304110B1 (en) | Process for the preparation of glutardialdehyde | |
| NO991158L (en) | Procedure for the treatment of amyotrophic lateral sclerosis | |
| NO982562D0 (en) | Composition for the treatment of pain | |
| NO984189D0 (en) | Procedure for the treatment of bipolar disorder | |
| NO962812D0 (en) | Procedure for the treatment of pneumonia | |
| NO986053D0 (en) | Anticonvulsant derivatives for the treatment of psoriasis | |
| NO972682D0 (en) | New process for the preparation of sameridine | |
| NO972129D0 (en) | Process for the preparation of 1-halo-3-trialkylsilanyl-benzene derivatives | |
| NO20003077D0 (en) | Process for the preparation of the chlorobenzoxazole | |
| NO964291D0 (en) | Procedure for the treatment of allergic rhinitis | |
| NO984190D0 (en) | Procedure for the treatment of insomnia | |
| NO994557D0 (en) | Process for the preparation of arylaminotriazolopyridines |